Africa’s health systems were creaking even before the covid-19 pandemic and the cause was the continent’s low capacity in the manufacturing of medicine locally, the delays in shipping drugs to the continent, and after months of waiting, the high costs especially to customers outside of urban areas. But during a plenary on Africa’s health supply chains at the US-Africa Business Summit in Morocco on July 22, health experts called on big pharma to direct their investments to Africa and manufacture on the continent. Acting director of the Africa Centers for Disease Control (CDC) Ahmed Ouma said there’s an existing body of knowledge on traditional medicine in Africa which the US and other foreign investors can tap into and set up manufacturing plants in the continent. “Come and manufacture from here. We will support you,” said Ouma. Ouma stressed how, despite Africa’s huge opportunities, its health sector is still plagued by roadblocks in getting cold chain medical equipment, the appropriateness of the equipment in terms of power and movement and lack of personnel to use that equipment. The medical equipment market in the continent is projected to hit $7 billion by 2027.
SOURCE: QUARTZ AFRICA
More Stories
Launching a Local Lesotho Airline within the Next Year
Providing Support and Acceleration to Women-owned African Tech Startups
Journos Fight For their Voices to Be Heard
Containing a Measles Outbreak in Harare
African Leaders are Increasingly Aspiring to “Modernise” their Cities
UK to Cut Taxes on Imports from Africa
20 African Countries with the Highest Net Migration Rates
Kenyan Woman’s Campaign to Treat Sickle Cell
The Plight of South African Miners Continues
Odinga Won’t Accept Election Result
Mobile “Play-to-earn” App Enables Gamers of Every Level to Earn Cash in every Match they Play
A Device Designed to Make Computing and Computers Accessible to all Africans